Drug Trials Snapshots: STIOLTO RESPIMAT | FDA
STIOLTO RESPIMAT is a long-term treatment for adults with a lung disease called COPD (chronic obstructive pulmonary disease). It is a combination of two drugs already used for COPD.
Real-World Efficacy of BDP/FF/G Fixed Triple Inhalation Powder ...
6 days ago · Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality worldwide, placing a significant burden on healthcare systems and patients’ …
Stiolto Respimat for the Treatment of Chronic ... - Clinical Trials …
Jun 3, 2015 · Stiolto Respimat was approved by the US Food and Drug Administration (FDA) in May 2015 as a long-term, once-daily maintenance treatment for airflow obstruction in patients …
May 9, 2018 · The primary objective of this pragmatic study is to compare the time to first moderate or severe COPD exacerbation in patients, not controlled on their current therapy, …
CLINICAL TRIALS PROFILE FOR STIOLTO RESPIMAT
6 days ago · Ongoing or completed Phase IV studies are assessing long-term safety and real-world effectiveness, with some investigating the drug's utility in patients with asthma-COPD …
COPD Clinical Trials | BIPI Medical & Clinical Resources
Discover completed and ongoing clinical trials on investigational treatments and drug therapies for Chronic Obstructive Pulmonary Disease (COPD).
Assessment In a Real World Setting of the Effect of Inhaled Steroid ...
The primary objective of this pragmatic study is to compare the time to first moderate or severe COPD exacerbation in patients, not controlled on their current therapy, randomized to Stiolto …
COPD Inhalation Therapy, Stiolto Respimat, Seen as Superior...
Feb 12, 2016 · Stiolto Respimat was approved in 2015 for long-term treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is counter …
The Real-World Efficacy of Fixed Triple Inhalation Therapy in the ...
Apr 17, 2024 · Adherence to multi-inhaler triple therapy in routine clinical practice is known to be poorer than with fixed combinations, potentially influencing therapeutic outcomes. 15 …
STIOLTO RESPIMAT is a combination of tiotropium and olodaterol indicated for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), …